Manipal Health Enterprises Q1 Results 2027: Revenue Rises 38% YoY, PAT Falls 8% to ₹232 Cr
Manipal Health Enterprises reported strong revenue and EBITDA growth in Q1 FY27, but PAT declined year-on-year as margins moderated. Check the company's Q1 FY27 revenue, EBITDA, PAT and EPS performance.
Manipal Health Enterprises Q1 Results FY2027: Manipal Health Enterprises reported 38.10% YoY revenue growth to ₹3,090.63 crore in Q1 FY27. EBITDA increased 25.59% to ₹736.61 crore, while PAT attributable to owners of the company declined 7.49% to ₹231.65 crore. EBITDA and PAT margins declined compared with Q1 FY26.
Manipal Health Enterprises Q1 Results FY2027: On 20 August 2026, Manipal Health Enterprises announced its financial results for the first quarter ended 30 June 2026. Revenue from Operations increased 38.10% YoY to ₹3,090.63 crore compared with ₹2,237.63 crore in Q1 FY26.
While Profit After Tax (PAT) stood at ₹243.43 crore compared with ₹254.04 crore in Q1 FY26, registering a 4.18% YoY decline. PAT attributable to owners of the company stood at ₹231.65 crore, compared with ₹250.37 crore in Q1 FY26, declining 7.47% YoY. EBITDA Margin stood at 23.84% during the quarter.
Manipal Health Enterprises' share price closed 2.75% lower on 20 August 2026. The stock has gained 8.83% since its listing on 5 August 2026.
Manipal Health Enterprises Q1 FY27 Results Highlights
-
Revenue from Operations stood at ₹3,090.63 crore, registering a 38.10% YoY increase from ₹2,237.63 crore in Q1 FY26. Compared with ₹2,882.35 crore in Q4 FY26, revenue increased 7.23% QoQ.
-
Total Revenue stood at ₹3,165.19 crore, registering a 38.47% YoY increase from ₹2,285.98 crore in Q1 FY26. Compared with ₹2,917.85 crore in Q4 FY26, total revenue increased 8.48% QoQ.
-
EBITDA (Excluding Other Income) stood at ₹736.61 crore, compared with ₹586.48 crore in Q1 FY26, registering a 25.60% YoY increase. Compared with ₹691.16 crore in Q4 FY26, EBITDA increased 6.57% QoQ.
-
EBITDA Margin stood at 23.84%, compared with 26.20% in Q1 FY26 and 24.00% in Q4 FY26, declining by 2.36 percentage points YoY and 0.16 percentage points QoQ.
-
Profit After Tax (PAT) stood at ₹243.43 crore, compared with ₹254.04 crore in Q1 FY26, with profit declining 4.18% YoY. Compared with ₹186.53 crore in Q4 FY26, PAT increased 30.50% QoQ.
-
PAT Margin stood at 7.88%, compared with 11.37% in Q1 FY26 and 6.45% in Q4 FY26, declining by 3.49 percentage points YoY and expanding by 1.43 percentage points QoQ.
-
PAT attributable to owners of the company stood at ₹231.65 crore, compared with ₹250.37 crore in Q1 FY26, declining 7.47% YoY. Compared with ₹177.65 crore in Q4 FY26, PAT attributable to owners increased 30.39% QoQ.
-
EPS stood at ₹1.96, compared with ₹2.17 in Q1 FY26, declining 9.68% YoY. Compared with ₹1.53 in Q4 FY26, EPS increased 28.10% QoQ.
READ THIS ALSO: Tempsens Instruments (India) IPO Day 1
Manipal Health Enterprises Q1 FY27 Financial Summary
|
Metric |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Revenue from Operations (₹ Cr) |
3,090.63 |
2,882.35 |
+7.20% |
2,237.63 |
+38.10% |
|
Total Revenue (₹ Cr) |
3,165.19 |
2,917.85 |
+8.50% |
2,285.98 |
+38.50% |
|
EBITDA (₹ Cr) |
736.61 |
691.16 |
+6.60% |
586.48 |
+25.60% |
|
EBITDA Margin |
23.80% |
24.00% |
-0.20 pp |
26.20% |
-2.40 pp |
|
PAT (₹ Cr) |
243.43 |
186.53 |
+30.50% |
254.04 |
-4.20% |
|
PAT Margin |
7.90% |
6.50% |
+1.40 pp |
11.40% |
-3.50 pp |
|
PAT (Owners) (₹ Cr) |
231.65 |
177.65 |
+30.40% |
250.37 |
-7.50% |
|
EPS (₹) |
1.96 |
1.53 |
+28.10% |
2.17 |
-9.70% |
Source: Company Filing
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.